Eli Lilly’s weight-loss pill didn’t work so well, and the stock is tumblingBy Mario Cazombo / August 7, 2025 Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Book Review: The Financial Restructuring Tool Set August 6, 2025 / Book Reviews, Corporate Finance, Drivers of Value, Economics, Financial Statement Analysis, General
